Aspirin as adjuvant therapy for colorectal cancer - Reinterpreting paradigms
A high-quality body of evidence supports the use of aspirin in reducing sporadic and hereditary adenomatous polyps, and numerous observational studies point to a reduction in colorectal cancer (CRC) risk. However, using aspirin as an adjuvant therapy in established CRC was until recently inconceivab...
| 主要な著者: | , , |
|---|---|
| フォーマット: | Journal article |
| 出版事項: |
2012
|
Search Result 1
Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms.
出版事項 2012
Journal article